A Research Study of a New Medicine NNC0363-1063 in Participants With Type 1 Diabetes

NCT07305805 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: NNC0363-1063

Sponsor

Novo Nordisk A/S